name: tumor necrosis factor receptor superfamily member 6 isoform 6

description: A tumor necrosis factor receptor superfamily member 6 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P25445-6 or a 1:1 ortholog thereof.


name: tumor necrosis factor receptor superfamily member 6 isoform 6 (human)

description: A tumor necrosis factor receptor superfamily member 6 isoform 6 that is encoded in the genome of human.


A 7-deazaguanine ribonucleoside that is queuosine having a alpha-D-mannosyl residue attached at position 4''.


alpha-D-mannoside

Any mannoside in which the anomeric centre has alpha-configuration.


A disaccharide that is D-galactose in which the hydroxy group at position 2 has been converted into the corresponding alpha-D-mannopyranoside.


An alpha-D-glucoside that is (27R)-1,27-dihydroxyoctacosan-3-one on which the hydroxyl hydrogen at position 1 has been replaced by an alpha-D-mannosyl residue.


A polysaccharide composed of alpha-D-mannose joined by a (1->4)-linkage to a poly[3-O-methyl-alpha-D-mannosyl] group which is further linked to a 1-O,3-O-dimethyl-alpha-D-mannose via a (1->4)-linkage.


Any alpha-D-mannoside derived from 6-phospho-alpha-D-mannose.


An indolyl carbohydrate that is the alpha-D-mannoside of indoxyl in which the indole moiety is substituted at positions 4 and 5 by chlorine and bromine, respectively


p-aminophenyl alpha-D-mannoside

An alpha-D-mannoside having 4-aminophenyl as the anomeric substituent.


Any alpha-D-mannoside derived from 2,4-di-O-phospho-alpha-D-mannose


Any alpha-D-mannoside derived from 6-(alpha-D-glucose-1-phospho)-alpha-D-mannose.


Any alpha-D-mannoside derived from 6-(N-acetyl-alpha-D-glucosaminyl-1-phospho)-alpha-D-mannose.


methyl alpha-D-mannoside

A methyl mannoside having alpha-configuration at the anomeric centre.


An alpha-D-Manp-(1->2)-D-Galp in which the carbon bearing the anomeric hydroxy group has alpha configuration.


proline salvage

category: biolink:BiologicalProcess biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: Any process which produces the amino acid proline from derivatives of it, without de novo synthesis.


proline biosynthetic process

description: The chemical reactions and pathways resulting in the formation of proline (pyrrolidine-2-carboxylic acid), a chiral, cyclic, nonessential alpha-amino acid found in peptide linkage in proteins.


name: C71BD_ARATH Cytochrome P450 71B13 (sprot)

description: A protein that is a translation product of the CYP71B13 gene in Arabidopsis thaliana.


name: uncharacterized protein C4orf3 isoform h2 (human)

description: An uncharacterized protein C4orf3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WVX3-2.


name: CD003_HUMAN Uncharacterized protein C4orf3 (sprot)

description: An uncharacterized protein C4orf3 that is encoded in the genome of human.


name: uncharacterized protein C4orf3 isoform h1 (human)

description: An uncharacterized protein C4orf3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WVX3-1.


name: AXR4_ARATH Protein AUXIN RESPONSE 4 (sprot)

description: A protein that is a translation product of the AXR4 gene in Arabidopsis thaliana.


name: epithelial cell of early distal convoluted tubule

category: biolink:Cell biolink:AnatomicalEntity biolink:PhysicalEssence biolink:OrganismalEntity biolink:SubjectOfInvestigation biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: An epithelial cell located in the early distal convoluted tubule.


name: kidney distal convoluted tubule epithelial cell

description: Any epithelial cell of distal tubule that is part of some distal convoluted tubule.


name: epithelial cell of late distal convoluted tubule

description: An epithelial cell located in the late distal convoluted tubule.


name: YDDM_ECOLI Uncharacterized HTH-type transcriptional regulator YddM (sprot)

description: An uncharacterized HTH-type transcriptional regulator YddM that is encoded in the genome of Escherichia coli K-12.


name: olfactory receptor 6A2 isoform 1 (human)

description: An olfactory receptor 6A2 isoform 1 that is encoded in the genome of human.


olfactory receptor 6A2 isoform 1

An olfactory receptor 6A2 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O95222-1 or a 1:1 ortholog thereof.


olfactory receptor 226 isoform 1 (rat)

An olfactory receptor 6A2 isoform 1 that is encoded in the genome of rat.


name: intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing


DNA ligase 1 isoform h2 (human)

A DNA ligase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P18858-2.


A member of the class of phenanthrolines that is 4,7-diphenyl-1,10-phenanthroline carrying two additional sulfo substituents at positions 4' and 4''


YAFZ_ECOLI UPF0380 protein YafZ (sprot)

A UPF0380 protein YafZ that is encoded in the genome of Escherichia coli K-12.


Stage IA2 Lung Cancer AJCC v8

description: Stage IA2 includes: T1b, N0, M0. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. N0: No regional lymph node metastases. M0: No distant metastasis. (AJCC 8th ed.)


myositis ossificans, cattle

description: Myositis ossificans that occurs in cattle.


myositis ossificans, non-human animal

description: Myositis ossificans that occurs in non-human animals.


myositis ossificans, pig

description: Myositis ossificans that occurs in pig.


name: intercellular adhesion molecule 4, signal peptide removed form (human)

description: An intercellular adhesion molecule 4 (human) that has had the signal peptide removed. UniProtKB:Q14773, 23-271.


name: Y3210_ARATH BTB/POZ domain-containing protein At3g22104 (sprot)

description: A protein that is a translation product of the At3g22104 gene in Arabidopsis thaliana.


name: tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform 1 (mouse)

description: A tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform 1 that is encoded in the genome of mouse.


name: OSGL1_MOUSE tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (sprot)

description: A tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial that is encoded in the genome of mouse.


name: tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform m2 (mouse)

description: A tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6PEB4-2.


name: lipoprotein biosynthetic process via signal peptide cleavage

description: The chemical reactions and pathways by which signal peptide cleavage leads to formation of a water-soluble protein-lipid complex.


name: B-cell linker protein isoform h3 (human)

description: A B-cell linker protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WV28-3.


name: BRCA1-associated RING domain protein 1 isoform beta (human)

description: A BRCA1-associated RING domain protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q99728-3.


name: alpha-aminoadipic semialdehyde synthase isoform Short (Arabidopsis thaliana)

description: An alpha-aminoadipic semialdehyde synthase (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9SMZ4-2.


A member of the class of  chromenes that is 2H-1-benzopyran-7-ol acetate substituted by methyl groups at positions 2 and 2, an ethyl group at position 4 and a 4-methoxyphenyl group at position 3 respectively.


name: ferredoxin-fold anticodon-binding domain-containing protein 1 isoform h2 (human)

description: A ferredoxin-fold anticodon-binding domain-containing protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BRP7-2.


name: FDXA1_HUMAN Ferredoxin-fold anticodon-binding domain-containing protein 1 (sprot)

description: A ferredoxin-fold anticodon-binding domain-containing protein 1 that is encoded in the genome of human.


name: ferredoxin-fold anticodon-binding domain-containing protein 1 phosphorylated 1 (human)

description: A ferredoxin-fold anticodon-binding domain-containing protein 1 (human) that has been phosphorylated on the residue at the position equivalent to Ser-476 of the amino acid sequence represented by UniProtKB:Q9BRP7-1. Example: UniProtKB:Q9BRP7-1, Ser-476, MOD:00046.


name: ferredoxin-fold anticodon-binding domain-containing protein 1 isoform h1 (human)

description: A ferredoxin-fold anticodon-binding domain-containing protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BRP7-1.


name: CSU2_ARATH Protein COP1 SUPPRESSOR 2 (sprot)

description: A splicing factor C9orf78 that is encoded in the genome of Arabidopsis thaliana.


name: regulatory protein SWI6 phosphorylated 1 (yeast)

description: A regulatory protein SWI6 (yeast) that has been phosphorylated at Ser-238. UniProtKB:P09959, Ser-238, MOD:00046.


name: SWI6_YEAST Regulatory protein SWI6 (sprot)

description: A protein that is a translation product of the SWI6 gene in yeast.


malectin isoform 1 (rat)

A malectin isoform 1 that is encoded in the genome of rat.


name: YKQA_CAEEL Uncharacterized protein C06E1.11 (sprot)

description: A protein that is a translation product of the C06E1.11 gene in worm.


name: X-ray repair cross-complementing protein 5 cysteinylated 2 (human)

description: An X-ray repair cross-complementing protein 5 (human) that has been cysteinylated on the residue at the position equivalent to Cys-493 of the amino acid sequence represented by UniProtKB:P13010. UniProtKB:P13010, Cys-493, MOD:00765.


name: ocular dysgenesis caused by defects in PAX6 regulation

description: Any eye disorder in which the cause of the disease is a variant in the PAX6 gene itself or a variant within another locus that results in defective regulation of the PAX6 gene.


name: histone deacetylase 11 cysteinylated 1 (mouse)

description: A histone deacetylase 11 (mouse) that has been cysteinylated on the residue at the position equivalent to Cys-331 of the amino acid sequence represented by UniProtKB:Q91WA3. UniProtKB:Q91WA3, Cys-331, MOD:00765.


name: multidrug and toxin extrusion protein 1 isoform h2 (human)

description: A multidrug and toxin extrusion protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96FL8-2.


name: UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity

category: biolink:MolecularActivity biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: Catalysis of the removal of an acetyl group from the 2-N position of glucosamine in the lipid A precursor UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine.


Conjugate base of bkas#14


A cationic peptidyl group obtained by protonation of the two amino groups of an glycyl-L-lysyl-L-glutamate residue.


name: Metastatic malignant neoplasm to prostate

description: The spread of a malignant neoplasm to the prostate gland from an adjacent or distant anatomic site.


name: Metastatic Malignant Neoplasm in the Male Reproductive System

description: The spread of a malignant neoplasm to the male reproductive system from an adjacent or distant anatomic site.


Secondary Prostate Urothelial Carcinoma

description: A transitional cell carcinoma that has spread to the prostate gland directly from the bladder.


name: Metastatic malignant neoplasm to seminal vesicle

description: The spread of a malignant neoplasm to the seminal vesicle from an adjacent or distant anatomic site.


Metastatic malignant neoplasm to testis

description: A malignant neoplasm that has spread to the testis from another anatomic site.


name: Metastatic malignant neoplasm to epididymis

description: A malignant neoplasm that has metastasized to the epididymis from another anatomic site.


Metastatic malignant neoplasm to penis

description: The spread of a malignant neoplasm to the penis from an adjacent or distant anatomic site.


name: F-box/LRR-repeat protein 4 isoform 1 (mouse)

description: An F-box/LRR-repeat protein 4 isoform 1 that is encoded in the genome of mouse.


F-box/LRR-repeat protein 4 isoform 1

An F-box/LRR-repeat protein 4 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UKA2-1 or a 1:1 ortholog thereof.


name: F-box/LRR-repeat protein 4 isoform 1 (human)

description: An F-box/LRR-repeat protein 4 isoform 1 that is encoded in the genome of human.


name: autism susceptibility gene 2 protein homolog isoform m3 (mouse)

description: An autism susceptibility gene 2 protein homolog (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A0A087WPF7-3.


atrazine catabolic process to urea

description: The chemical reactions and pathways resulting in the breakdown of atrazine, a triazine ring-containing herbicide, into urea.


amide catabolic process

description: The chemical reactions and pathways resulting in the breakdown of an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group.


name: L-histidine catabolic process to glutamate and formamide

description: The chemical reactions and pathways resulting in the breakdown of L-histidine into other compounds, including glutamate and formamide.


formamide catabolic process

description: The chemical reactions and pathways resulting in the breakdown of formamide, the simplest amide, HCONH2, derived from formic acid.


urea catabolic process

description: The chemical reactions and pathways resulting in the breakdown of urea, the water soluble compound O=C-(NH2)2.


allantoin assimilation pathway

description: The pathways by which allantoin is processed and converted to ureidoglycolate, and then into metabolically useful substrates. E. coli are able to utilize allantoin as a sole nitrogen source under anaerobic conditions by converting it to ureidoglycolate; this may be further metabolized to produce glyoxylate and thence 3-phosphoglycerate, or alternatively oxidized to oxolureate, which can converted into oxamate and carbamoylphosphate. This may then be further metabolized to CO2, NH4+ and ATP.


allantoin catabolic process

description: The chemical reactions and pathways resulting in the breakdown of allantoin, (2,5-dioxo-4-imidazolidinyl)urea.


biotin catabolic process

description: The chemical reactions and pathways resulting in the breakdown of biotin, cis-tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid.


name: electrogenic sodium bicarbonate cotransporter 1 sequence variant G427L (human)

description: An electrogenic sodium bicarbonate cotransporter 1 (human) that has a Leu residue at the position equivalent to Gly-427 of the amino acid sequence represented by UniProtKB:Q9Y6R1-1. Example: UniProtKB:Q9Y6R1-1, Gly-427, CHEBI:30006.


elongin-B isoform 1 (mouse)

An elongin-B isoform 1 that is encoded in the genome of mouse.


name: TRIML_HUMAN Probable E3 ubiquitin-protein ligase TRIML1 (sprot)

description: A probable E3 ubiquitin-protein ligase TRIML1 that is encoded in the genome of human.


name: probable E3 ubiquitin-protein ligase TRIML1

description: A protein that is a translation product of the human TRIML1 gene or a 1:1 ortholog thereof.


name: TRIML_MOUSE Probable E3 ubiquitin-protein ligase TRIML1 (sprot)

description: A probable E3 ubiquitin-protein ligase TRIML1 that is encoded in the genome of mouse.


name: TXD11_MOUSE Thioredoxin domain-containing protein 11 (sprot)

description: A thioredoxin domain-containing protein 11 that is encoded in the genome of mouse.


name: thioredoxin domain-containing protein 11 isoform m1 (mouse)

description: A thioredoxin domain-containing protein 11 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8K2W3-1.


name: thioredoxin domain-containing protein 11 isoform m2 (mouse)

description: A thioredoxin domain-containing protein 11 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8K2W3-2.


name: E3 ubiquitin-protein ligase DTX3L cysteinylated 1 (human)

description: An E3 ubiquitin-protein ligase DTX3L (human) that has been cysteinylated on the residue at the position equivalent to Cys-577 of the amino acid sequence represented by UniProtKB:Q8TDB6-1. Example: UniProtKB:Q8TDB6-1, Cys-577, MOD:00765.


O-hexadecanedioyl-L-carnitine

An O-acyl-L-carnitine in which the acyl group is specified as hexadecanedioyl.


VOME_MOUSE Vomeromodulin (sprot)

A protein that is a translation product of the Bpifb9a gene in mouse.


vomeromodulin isoform m2 (mouse)

A vomeromodulin (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q80XI7-2.


vomeromodulin isoform m1 (mouse)

A vomeromodulin (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q80XI7-1.


ORML3_DANRE ORM1-like protein 3 (sprot)

An ORM1-like protein 3 that is encoded in the genome of zebrafish.


name: ORM1-like protein 3 isoform 1 (zebrafish)

description: An ORM1-like protein 3 isoform 1 that is encoded in the genome of zebrafish.


JARD2_DANRE Protein Jumonji (sprot)

A protein Jumonji that is encoded in the genome of zebrafish.


name: tyrosine-protein phosphatase non-receptor type 1 methylated 2 (human)

description: A tyrosine-protein phosphatase non-receptor type 1 (human) that has been methylated on the residue at the position equivalent to Cys-121 of the amino acid sequence represented by UniProtKB:P18031. UniProtKB:P18031, Cys-121, MOD:00660.


name: tyrosine-protein phosphatase non-receptor type 1 phosphorylated 1 (human)

description: A tyrosine-protein phosphatase non-receptor type 1 (human) that has been phosphorylated at Tyr-66. UniProtKB:P18031, Tyr-66, MOD:00048.


name: tyrosine-protein phosphatase non-receptor type 1 methylated 1 (human)

description: A tyrosine-protein phosphatase non-receptor type 1 (human) that has been methylated on the residue at the position equivalent to Cys-426 of the amino acid sequence represented by UniProtKB:P18031. UniProtKB:P18031, Cys-426, MOD:00660.


name: elongation factor G isoform 1 (Escherichia coli K-12)

description: An elongation factor G isoform 1 that is encoded in the genome of Escherichia coli K-12.


elongation factor G isoform 1

An elongation factor G that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P0A6M8-1 or a 1:1 ortholog thereof.


name: elongation factor G isoform 1, initiator methionine removed form (Escherichia coli K-12)

description: An elongation factor G isoform 1, initiator methionine removed form in Escherichia coli K-12. UniProtKB:P0A6M8-1, 2-704.


name: elongation factor G isoform 1, initiator methionine removed acetylated 1 (Escherichia coli K-12)

description: An elongation factor G isoform 1, initiator methionine removed acetylated 1 in Escherichia coli K-12. UniProtKB:P0A6M8-1, 2-704, Lys-504/Lys-643, MOD:00064.


name: elongation factor G isoform 1, initiator methionine removed form

description: An elongation factor G isoform 1 that has had the initiator methionine removed.


name: elongation factor G isoform 1, initiator methionine removed acetylated 1

description: An elongation factor G isoform 1, initiator methionine removed form that has been post-translationally modified to include N6-acetyllysine residues. Example: UniProtKB:P0A6M8-1, 2-704, Lys-504/Lys-643, MOD:00064.


name: FUCO_MOUSE Tissue alpha-L-fucosidase (sprot)

description: A tissue alpha-L-fucosidase that is encoded in the genome of mouse.


name: fibroblast growth factor receptor-like 1 isoform 2 (rat)

description: A fibroblast growth factor receptor-like 1 isoform 2 that is encoded in the genome of rat.


name: SMIM1_MOUSE Small integral membrane protein 1 (sprot)

description: A small integral membrane protein 1 that is encoded in the genome of mouse.


A monoatomic trication derived from gallium.


elemental gallium

An element in the boron group of the periodic table with atomic number 31, atomic mass 69.723, M.P. 29.7646 C, and B.P. 2400 C.


flotufolastat F-18 gallium

An (18)F radiopharmaceutical which is used as a radioactive diagnostic agent for positron emission tomography (PET) of prostate-specific membrane antigen positive lesions in men with prostate cancer.


description: A cholangiocarcinoma that has developed following infection with Opisthorchis viverrini.


name: Stage 0 Hilar Cholangiocarcinoma AJCC v8

description: Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ/high grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Locally Advanced Distal Bile Duct Carcinoma

description: Distal bile duct carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.


name: Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7

description: Stage IVB includes: Any T, Any N, M1.  M1: Distant metastasis. (from AJCC 7th Ed.)


name: Stage IA Intrahepatic Cholangiocarcinoma AJCC v8

description: Stage IA includes: T1a, N0, M0. T1a: Solitary tumor equal or less than 5 cm without vascular invasion.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Cholangiocarcinoma resectable

description: Cholangiocarcinoma that is amenable to surgical resection.


Metastatic Bile Duct Carcinoma

description: A carcinoma that arises from the intrahepatic or extrahepatic bile ducts and has metastasized to other anatomic sites.


name: Advanced Extrahepatic Bile Duct Carcinoma

description: Extrahepatic bile duct carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Stage IVB Hilar Cholangiocarcinoma AJCC v8

description: Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)


name: Stage IB Distal Bile Duct Cancer AJCC v7

description: Stage IB includes: T2, N0, M0. T2: Tumor invades beyond the wall of the bile duct.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Localized Extrahepatic Bile Duct Carcinoma

description: A carcinoma that arises from the extrahepatic bile ducts and it has not spread to other anatomic sites.


name: Stage IIIB Hilar Cholangiocarcinoma AJCC v7

description: Stage IIIB includes: T1-3, N1, M0. T1: Tumor confined to the bile duct, with extension up to the muscle layer or fibrous tissue.  T2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue.  T2b: Tumor invades adjacent hepatic parenchyma.  T3: Tumor invades unilateral branches of the portal vein or hepatic artery.  N1: Regional lymph node metastasis (including nodes along the cystic duct, common bile duct, hepatic artery, and portal vein).  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Hilar Cholangiocarcinoma by AJCC v7 Stage

description: A term that refers to the staging of hilar cholangiocarcinoma according to the American Joint Committee on Cancer, 7th edition.


Cholangiocarcinoma non-resectable

description: Cholangiocarcinoma that is not amenable to surgical resection.


name: Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7

description: Stage IVA includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor with periductal invasion. N0: No regional lymph node metastasis.  N1: Regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


Distal Bile Duct Adenocarcinoma

description: An adenocarcinoma that arises from the common bile duct distal to the insertion of the cystic duct.


name: Clear Cell Intrahepatic Cholangiocarcinoma

description: A morphologic variant of intrahepatic cholangiocarcinoma composed of malignant glandular epithelium, an abundant fibrous stroma, and the presence of clear cells. Clinical symptoms include abdominal pain, weight loss and malaise.


Stage I Distal Bile Duct Cancer AJCC v8

description: Stage I includes: T1, N0, M0. T1: Tumor invading the bile duct wall with a depth less than 5 mm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Metastatic Hilar Cholangiocarcinoma

description: Hilar cholangiocarcinoma that has spread from its original site of growth to another anatomic site.


name: Stage IIIC Hilar Cholangiocarcinoma AJCC v8

description: Stage IIIC includes: Any T, N1, M0. N1: One to three positive lymph nodes typically involving the hilar, cystic duct, common bile duct, hepatic artery, posterior pancreatoduodenal, and portal vein lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Unresectable Distal Bile Duct Adenocarcinoma

description: Distal bile duct adenocarcinoma that is not amenable to surgical resection.


name: Recurrent Distal Bile Duct Adenocarcinoma

description: The reemergence of distal bile duct adenocarcinoma after a period of remission.


name: Extrahepatic Bile Duct Neuroendocrine Carcinoma

description: An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the extrahepatic bile ducts. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm.


name: Stage I Hilar Cholangiocarcinoma AJCC v7

description: Stage I includes: T1, N0, M0. T1: Tumor confined to the bile duct, with extension up to the muscle layer or fibrous tissue.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Locally Advanced Unresectable Cholangiocarcinoma

description: Cholangiocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Stage IV Hilar Cholangiocarcinoma AJCC v8

description: Stage IV includes: IVA: (Any T, N2, M0); IVB: (Any T, Any N, M1). N2: Four or more positive lymph nodes involving the hilar, cystic duct, common bile duct, hepatic artery, posterior pancreatoduodenal, and portal vein lymph nodes. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)


Bile duct cancer resectable

description: Extrahepatic bile duct carcinoma that is amenable to surgical removal.


Locally Advanced Bile Duct Carcinoma

description: A bile duct carcinoma that has spread to nearby tissues or lymph nodes.


Metastatic cholangiocarcinoma

description: A cholangiocarcinoma that has metastasized to other anatomic sites.


Advanced Bile Duct Carcinoma

description: A carcinoma that arises from the intrahepatic or extrahepatic bile ducts and has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Stage IVA Hilar Cholangiocarcinoma AJCC v7

description: Stage IVA includes: T4, N0-1, M0. T4: Tumor invades the main portal vein or its branches bilaterally; or the common hepatic artery; or the second-order biliary radicals bilaterally; or unilateral second-order biliary radicals with contralateral portal vein or hepatic artery involvement.  N0: No regional lymph node metastasis.  N1: Regional lymph node metastasis (including nodes along the cystic duct, common bile duct, hepatic artery, and portal vein).  M0: No distant metastasis.  (from AJCC 7th Ed.)


name: Locally Advanced Intrahepatic Cholangiocarcinoma

description: Intrahepatic cholangiocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.


name: Metastatic Distal Bile Duct Adenocarcinoma

description: Distal bile duct adenocarcinoma that has spread from its original site of growth to another anatomic site.


name: intestinal type adenocarcinoma of extrahepatic bile duct

description: An adenocarcinoma that arises from the extrahepatic bile ducts.  It is characterized by the presence of neoplastic tubular glands lined by columnar cells or neoplastic glands lined by goblet cells.


Bile duct cancer recurrent

description: The reemergence of bile duct carcinoma after a period of remission.


name: Stage III Intrahepatic Cholangiocarcinoma AJCC v8

description: Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0); (Any T, N1, M0). T3: Tumor perforating the visceral peritoneum. T4: Tumor involving local extrahepatic structures by direct invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage IV Distal Bile Duct Cancer AJCC v8

description: Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)


description: Intrahepatic cholangiocarcinoma that has metastasized to a limited number of sites.


name: Stage III Intrahepatic Cholangiocarcinoma AJCC v7

description: Stage III includes: T3, N0, M0. T3: Tumor perforating the visceral peritoneum or involving the local extra hepatic structures by direct invasion. N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Stage IIIA Distal Bile Duct Cancer AJCC v8

description: Stage IIIA includes: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0). T1: Tumor invading the bile duct wall with a depth less than 5 mm. T2: Tumor invading the bile duct wall with a depth of 5-12 mm. T3: Tumor invading the bile duct wall with a depth greater than 12 mm. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


Refractory Bile Duct Carcinoma

description: Bile duct carcinoma that is resistant to treatment.


name: Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8

description: Stage IIIB includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor involving local extrahepatic structures by direct invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


description: The reemergence of intrahepatic cholangiocarcinoma after a period of remission.


name: Recurrent Extrahepatic Bile Duct Carcinoma

description: The reemergence of an extrahepatic bile duct carcinoma after a period of remission.


name: Refractory Extrahepatic Bile Duct Carcinoma

description: Extrahepatic bile duct carcinoma that is resistant to treatment.


name: anaplastic carcinoma of extrahepatic bile duct

description: A carcinoma without evidence of differentiation arising from the extrahepatic bile ducts.


name: Hilar Cholangiocarcinoma by AJCC v8 Stage

description: A term that refers to the staging of hilar cholangiocarcinoma according to the American Joint Committee on Cancer, 8th edition. Hilar well-differentiated neuroendocrine tumors and sarcomas are not staged using this staging system. (from AJCC 8th Ed.)


name: Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7

description: Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ (intraductal tumor).  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Stage II Distal Bile Duct Cancer AJCC v8

description: Stage II includes: IIA: (T1, N1, M0); (T2, N0, M0); IIB: (T2, N1, M0); (T3, N0, M0); (T3, N1, M0). T1: Tumor invading the bile duct wall with a depth less than 5 mm. T2: Tumor invading the bile duct wall with a depth of 5-12 mm. T3: Tumor invading the bile duct wall with a depth greater than 12 mm. N0: No regional lymph node metastasis. N1: Metastasis in one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage IVA Hilar Cholangiocarcinoma AJCC v8

description: Stage IVA includes: Any T, N2, M0. N2: Four or more positive lymph nodes involving the hilar, cystic duct, common bile duct, hepatic artery, posterior pancreatoduodenal, and portal vein lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage I Hilar Cholangiocarcinoma AJCC v8

description: Stage I includes: T1, N0, M0. T1: Tumor confined to the bile duct, with extension up to the muscle layer or fibrous tissue. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage II Hilar Cholangiocarcinoma AJCC v8

description: Stage II includes: T2a-b, N0, M0. T2a: Tumor invading beyond the wall of the bile duct to surrounding adipose tissue. T2b: Tumor invading adjacent hepatic parenchyma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage II Intrahepatic Cholangiocarcinoma AJCC v8

description: Stage II includes: T2, N0, M0. T2: Solitary tumor with intrahepatic vascular invasion, or multiple tumors, with or without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma

description: An intraductal papillary neoplasm that arises from the epithelium of the intrahepatic or extrahepatic bile ducts and it is associated with an invasive carcinomatous component.


name: Intrahepatic Cholangiocarcinoma by AJCC v8 Stage

description: A term that refers to the staging of intrahepatic cholangiocarcinoma according to the American Joint Committee on Cancer, 8th edition.


name: Stage IV Intrahepatic Cholangiocarcinoma AJCC v8

description: Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)


name: Stage IIB Distal Bile Duct Cancer AJCC v7

description: Stage IIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0).  T1: Tumor confined to the bile duct histologically.  T2: Tumor invades beyond the wall of the bile duct. T3: Tumor invades the gallbladder, pancreas, duodenum, or other adjacent organs without involvement of the celiac axis or the superior mesenteric artery.  N1: Regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Stage IIIA Hilar Cholangiocarcinoma AJCC v8

description: Stage IIIA includes: T3, N0, M0. T3: Tumor invading unilateral branches of the portal vein or hepatic artery. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Distal Bile Duct Cancer by AJCC v8 Stage

description: A term that refers to the staging of distal bile duct cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to bile duct adenocarcinomas, biliary intraepithelial neoplasia, high-grade neuroendocrine carcinomas, and papillary carcinomas that arise from the distal bile duct. Tumors arising in the ampulla of Vater, sarcomas, and well-differentiated neuroendocrine tumors (carcinoids) are not staged using this staging system. (from AJCC 8th Ed.)


name: Metastatic Extrahepatic Bile Duct Carcinoma

description: Extrahepatic bile duct carcinoma that has spread from its original site of growth to another anatomic site.


name: Extrahepatic Bile Duct Adenocarcinoma, Biliary Type

description: A well or moderately differentiated adenocarcinoma that arises from the extrahepatic bile ducts.  It is characterized by the presence of malignant tubular glands.


name: Stage IB Intrahepatic Cholangiocarcinoma AJCC v8

description: Stage IB includes: T1b, N0, M0. T1b: Solitary tumor larger than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: carcinosarcoma of extrahepatic bile duct

description: A carcinoma that arises from the extrahepatic bile ducts and it is characterized by the presence of a sarcomatous component.


name: Stage IV Distal Bile Duct Cancer AJCC v7

description: Stage IV includes: Any T, Any N, M1. M1: Distant metastasis.  (from AJCC 7th Ed.)


name: Stage IIB Distal Bile Duct Cancer AJCC v8

description: Stage IIB includes: (T2, N1, M0); (T3, N0, M0); (T3, N1, M0). T2: Tumor invading the bile duct wall with a depth of 5-12 mm. T3: Tumor invading the bile duct wall with a depth greater than 12 mm. N0: No regional lymph node metastasis. N1: Metastasis in one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage 0 Hilar Cholangiocarcinoma AJCC v7

description: Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Stage IA Distal Bile Duct Cancer AJCC v7

description: Stage IA includes: T1, N0, M0. T1: Tumor confined to the bile duct histologically.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Locally Advanced Extrahepatic Bile Duct Carcinoma

description: Extrahepatic bile duct carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.


Unresectable Bile Duct Carcinoma

description: Bile duct carcinoma that is not amenable to surgical resection.


name: Stage IIIB Distal Bile Duct Cancer AJCC v8

description: Stage IIIB includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor involving the celiac axis, superior mesenteric artery, and/or common hepatic artery. N0: No regional lymph node metastasis. N1: Metastasis in one to three regional lymph nodes. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage IVB Hilar Cholangiocarcinoma AJCC v7

description: Stage IVB includes: (Any T, N2, M0); (Any T, Any N, M1).  N2: MetastasIs to periaortic, pericaval, superior mesenteric artery, and/or celiac artery lymph nodes.  M0: No distant metastasis.  M1: Distant metastasis. (from AJCC 7th Ed.)


description: Intrahepatic cholangiocarcinoma that has spread from its original site of growth to another anatomic site.


name: Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma

description: A carcinoma that arises from the extrahepatic bile ducts and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.


Unresectable Hilar Cholangiocarcinoma

description: Hilar cholangiocarcinoma that is not amenable to surgical resection.


name: Stage III Hilar Cholangiocarcinoma AJCC v8

description: Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0); IIIC: (Any T, N1, M0). T3: Tumor invading unilateral branches of the portal vein or hepatic artery. T4: Tumor invading the main portal vein or its branches bilaterally, or the common hepatic artery; or unilateral second-order biliary radicals with contralateral portal vein or hepatic artery involvement. N0: No regional lymph node metastasis. N1: One to three positive lymph nodes typically involving the hilar, cystic duct, common bile duct, hepatic artery, posterior pancreatoduodenal, and portal vein lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Intrahepatic Cholangiocarcinoma by AJCC v7 Stage

description: A term that refers to the staging of intrahepatic cholangiocarcinoma according to the American Joint Committee on Cancer, 7th edition.


name: Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8

description: Stage IIIA includes: T3, N0, M0. T3: Tumor perforating the visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage IIA Distal Bile Duct Cancer AJCC v8

description: Stage IIA includes: (T1, N1, M0); (T2, N0, M0). T1: Tumor invading the bile duct wall with a depth less than 5 mm. T2: Tumor invading the bile duct wall with a depth of 5-12 mm. N0: No regional lymph node metastasis. N1: Metastasis in one to three regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage II Intrahepatic Cholangiocarcinoma AJCC v7

description: Stage II includes: T2, N0, M0.  T2: Solitary tumor with vascular invasion or multiple tumors, with or without vascular invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Refractory Distal Bile Duct Adenocarcinoma

description: Distal bile duct adenocarcinoma that is resistant to treatment.


Metastatic Distal Bile Duct Carcinoma

description: A distal bile duct carcinoma that has spread from its original site of growth to other anatomic sites.


name: Extrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma

description: A papillary neoplasm that arises from the epithelium of the extrahepatic bile ducts and it is associated with an invasive carcinomatous component.  The carcinomatous component is an adenocarcinoma.


description: Intrahepatic cholangiocarcinoma that is amenable to surgical resection.


name: Stage IIA Distal Bile Duct Cancer AJCC v7

description: Stage IIA includes: T3, N0, M0.  T3: Tumor invades the gallbladder, pancreas, duodenum, or other adjacent organs without involvement of the celiac axis or the superior mesenteric artery.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


Cholangiocarcinoma recurrent

description: The reemergence of cholangiocarcinoma after a period of remission.


name: Small Duct Intrahepatic Cholangiocarcinoma

description: An intrahepatic cholangiocarcinoma that arises from the small interlobular bile ducts.


name: Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8

description: Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (intraductal tumor). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Distal Bile Duct Cancer by AJCC v7 Stage

description: A term that refers to the staging of distal bile duct cancer according to the American Joint Committee on Cancer, 7th edition.


description: Intrahepatic cholangiocarcinoma that is resistant to treatment.


name: Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type

description: An unusual, well differentiated adenocarcinoma that arises from the extrahepatic bile ducts.  It is characterized by the presence of tall malignant columnar cells with mucin-containing cytoplasm and basally located nuclei.


description: Intrahepatic cholangiocarcinoma that is not amenable to surgical removal.


name: Stage II Hilar Cholangiocarcinoma AJCC v7

description: Stage II includes: T2a-b, N0, M0.  T2a: Tumor invades beyond the wall of the bile duct to surrounding adipose tissue.  T2b: Tumor invades adjacent hepatic parenchyma.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Stage III Distal Bile Duct Cancer AJCC v7

description: Stage III includes: T4, Any N, M0. T4: Tumor involves the celiac axis or the superior mesenteric artery.  M0: No distant metastasis. (from AJCC 7th Ed.)


Locally Advanced Cholangiocarcinoma

description: Cholangiocarcinoma that has spread to nearby tissues or lymph nodes.


name: Stage I Intrahepatic Cholangiocarcinoma AJCC v8

description: Stage I includes: IA (T1a, N0, M0); IB (T1b, N0, M0). T1a: Solitary tumor equal or less than 5 cm without vascular invasion.  T1b: Solitary tumor larger than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Unresectable Extrahepatic Bile Duct Carcinoma

description: Extrahepatic bile duct carcinoma that is not amenable to surgical removal.


name: Stage IIIB Hilar Cholangiocarcinoma AJCC v8

description: Stage IIIB includes: T4, N0, M0. T4: Tumor invading the main portal vein or its branches bilaterally, or the common hepatic artery; or unilateral second-order biliary radicals with contralateral portal vein or hepatic artery involvement. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Resectable Extrahepatic Bile Duct Adenocarcinoma

description: Extrahepatic bile duct adenocarcinoma that is amenable to surgical resection.


name: Stage IIIA Hilar Cholangiocarcinoma AJCC v7

description: Stage IIIA includes: T3, N0, M0. T3: Tumor invades unilateral branches of the portal vein or hepatic artery.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Intrahepatic Bile Duct Intraductal Papillary Neoplasm with an Associated Invasive Carcinoma

description: A papillary neoplasm that arises from the epithelium of the intrahepatic bile ducts and it is associated with an invasive carcinomatous component.  The carcinomatous component is an intrahepatic cholangiocarcinoma.


name: Stage I Intrahepatic Cholangiocarcinoma AJCC v7

description: Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


name: Stage III Distal Bile Duct Cancer AJCC v8

description: Stage III includes: IIIA: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); IIIB: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T1: Tumor invading the bile duct wall with a depth less than 5 mm. T2: Tumor invading the bile duct wall with a depth of 5-12 mm. T3: Tumor invading the bile duct wall with a depth greater than 12 mm. T4: Tumor involving the celiac axis, superior mesenteric artery, and/or common hepatic artery. N0: No regional lymph node metastasis. N1: Metastasis in one to three regional lymph nodes. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)


Bile duct adenocarcinoma resectable

description: Bile duct adenocarcinoma that is amenable to surgical resection.


name: Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma

description: A mucinous cystic neoplasm that arises from the extrahepatic bile ducts and it is associated with an invasive carcinomatous component.


Stage 0 Distal Bile Duct Cancer AJCC v8

description: Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ/high-grade dysplasia. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Stage 0 Distal Bile Duct Cancer AJCC v7

description: Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (from AJCC 7th Ed.)


Refractory Cholangiocarcinoma

description: Cholangiocarcinoma that is resistant to treatment.


name: large cell neuroendocrine carcinoma of extrahepatic bile duct

description: An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the extrahepatic bile ducts.  It is characterized by the presence of malignant large cells.


A tetrasaccharide derivative that is a methyl tetraarabinofuranoside corresponding to part of the arabinomannanan portion of the lipoarabinomannan from Mycobacterium tuberculosis.


name: armadillo repeat-containing protein 1 isoform h2 (human)

description: An armadillo repeat-containing protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NVT9-2.


name: collagen alpha-6(VI) chain isoform m1 (mouse)

description: A collagen alpha-6(VI) chain (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8C6K9-1.


name: CO6A6_MOUSE Collagen alpha-6(VI) chain (sprot)

description: A collagen alpha-6(VI) chain that is encoded in the genome of mouse.


name: collagen alpha-6(VI) chain isoform m2 (mouse)

description: A collagen alpha-6(VI) chain (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8C6K9-2.


name: sorbin and SH3 domain-containing protein 1 isoform m5 (mouse)

description: A sorbin and SH3 domain-containing protein 1 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q62417-5.


name: NHR76_CAEEL Nuclear hormone receptor family member nhr-76 (sprot)

description: A protein that is a translation product of the nhr-76 gene in worm.


name: probable E3 ubiquitin-protein ligase HERC6 isoform h3 (human)

description: A probable E3 ubiquitin-protein ligase HERC6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IVU3-3.


name: uncharacterized ABC transporter ATP-binding protein YnjD

description: A protein that is a translation product of the Escherichia coli K-12 ynjD gene or a 1:1 ortholog thereof.


name: YNJD_ECOLI Uncharacterized ABC transporter ATP-binding protein YnjD (sprot)

description: An uncharacterized ABC transporter ATP-binding protein YnjD that is encoded in the genome of Escherichia coli K-12.


name: zinc finger protein 829 isoform h3 (human)

description: A zinc finger protein 829 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q3KNS6-3.


name: ectonucleotide pyrophosphatase/phosphodiesterase family member 2 isoform h2 (human)

description: An ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13822-2.


name: EP300-interacting inhibitor of differentiation 1 isoform h2 (human)

description: An EP300-interacting inhibitor of differentiation 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y6B2-2.


name: PHD finger protein 20-like protein 1 isoform h1 (human)

description: A PHD finger protein 20-like protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A8MW92-1.


PEDILSTATIN

A phorbol ester that is 4-deoxyphorbol in which the hydroxy groups at positions  12 and 13 have been replaced by octa-2,4-dienoyloxy and acetyloxy groups respectively.


name: RAD1_SCHPO DNA damage checkpoint control protein rad1 (sprot)

description: A cell cycle checkpoint protein RAD1 that is encoded in the genome of Schizosaccharomyces pombe 972h-.


name: adhesion G-protein coupled receptor G2 isoform h3 (human)

description: An adhesion G-protein coupled receptor G2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IZP9-3.


homeobox protein Hox-D4

A protein that is a translation product of the human HOXD4 gene or a 1:1 ortholog thereof.


name: HXD4_MOUSE Homeobox protein Hox-D4 (sprot)

description: A homeobox protein Hox-D4 that is encoded in the genome of mouse.


name: citramalyl-CoA lyase, mitochondrial isoform 1 (mouse)

description: A citramalyl-CoA lyase, mitochondrial isoform 1 that is encoded in the genome of mouse.


citramalyl-CoA lyase, mitochondrial

A protein that is a translation product of the human CLYBL gene or a 1:1 ortholog thereof.


name: citramalyl-CoA lyase, mitochondrial isoform h1 (human)

description: A citramalyl-CoA lyase, mitochondrial (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N0X4-1.


name: CLYBL_MOUSE Citramalyl-CoA lyase, mitochondrial (sprot)

description: A citramalyl-CoA lyase, mitochondrial that is encoded in the genome of mouse.


name: citramalyl-CoA lyase, mitochondrial isoform r2 (rat)

description: A citramalyl-CoA lyase, mitochondrial (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5I0K3-2.


name: citramalyl-CoA lyase, mitochondrial isoform 1

description: A citramalyl-CoA lyase, mitochondrial that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8R4N0-1 or a 1:1 ortholog thereof.


name: citramalyl-CoA lyase, mitochondrial isoform h2 (human)

description: A citramalyl-CoA lyase, mitochondrial (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N0X4-2.


name: CLYBL_RAT Citramalyl-CoA lyase, mitochondrial (sprot)

description: A citramalyl-CoA lyase, mitochondrial that is encoded in the genome of rat.


name: CLYBL_HUMAN Citramalyl-CoA lyase, mitochondrial (sprot)

description: A citramalyl-CoA lyase, mitochondrial that is encoded in the genome of human.


name: citramalyl-CoA lyase, mitochondrial isoform 1 (rat)

description: A citramalyl-CoA lyase, mitochondrial isoform 1 that is encoded in the genome of rat.


name: RL11_DROME Large ribosomal subunit protein uL5 (sprot)

description: A eukaryotic-type large ribosomal subunit protein uL5 that is encoded in the genome of fruit fly.


choroid spindle cell melanoma

description: A spindle cell melanoma that involves the optic choroid.


choroid epithelioid cell melanoma

description: A epithelioid cell melanoma that involves the optic choroid.


choroid necrotic melanoma

description: A choroid melanoma characterized by the presence of tumor cell necrosis.


choroid mixed cell melanoma

description: A mixed cell uveal melanoma that involves the optic choroid.


intermediate cell type choroid melanoma

description: Choroid melanoma characterized by the presence of intermediate cells which are similar to but smaller than epithelioid cells.


name: PRP39_SCHPO Pre-mRNA-processing factor 39 (sprot)

description: A pre-mRNA-processing factor 39 that is encoded in the genome of Schizosaccharomyces pombe 972h-.


fumaric aciduria

description: Fumaric aciduria (FA), an autosomal recessive metabolic disorder, is most often characterized by early onset but non-specific clinical signs: hypotonia, severe psychomotor impairment, convulsions, respiratory distress, feeding difficulties and frequent cerebral malformations, along with a distinctive facies. Some patients present with only moderate intellectual impairment.


zinc finger protein 24 isoform 1 (rat)

A zinc finger protein 24 isoform 1 that is encoded in the genome of rat.


benzene ring

A mancude six-membered monocyclic ring consisting of six carbon atoms and containing three double bonds.


name: transmembrane protein 232 isoform m1 (mouse)

description: A transmembrane protein 232 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5K6N0-1.


name: LPAR2_HUMAN Lysophosphatidic acid receptor 2 (sprot)

description: A lysophosphatidic acid receptor 2 that is encoded in the genome of human.


name: tripartite motif-containing protein 42 isoform 1 (human)

description: A tripartite motif-containing protein 42 isoform 1 that is encoded in the genome of human.


name: TRI42_HUMAN Tripartite motif-containing protein 42 (sprot)

description: A tripartite motif-containing protein 42 that is encoded in the genome of human.


name: tripartite motif-containing protein 42 isoform h2 (human)

description: A tripartite motif-containing protein 42 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IWZ5-2.


name: 2-[[(2-ethoxyphenyl)-oxomethyl]amino]acetic acid [2-(2,6-dimethyl-1-piperidinyl)-2-oxoethyl] ester


GGN_RAT Gametogenetin (sprot)

A gametogenetin that is encoded in the genome of rat.


name: protein SPA1-RELATED 3 isoform 2 (Arabidopsis thaliana)

description: A protein SPA1-RELATED 3 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9LJR3-2.


LSM7_ARATH Sm-like protein LSM7 (sprot)

A U6 snRNA-associated Sm-like protein LSm7 that is encoded in the genome of Arabidopsis thaliana.


vertebral artery insufficiency

description: A syndrome which occurs as a result of the occlusion of one of the vertebral arteries. It may be caused by atherosclerosis, embolism or hemorrhage. Collateral circulation through the circle of Willis is usually comprised as well. Clinical signs may include vertigo, nystagmus, dysarthria, ataxia and sensorimotor deficits. Clinical course may lead to persistence of neurologic deficits. Prognosis is variable with a substantial risk for recurrent infarction.


name: EEPD1_MOUSE Endonuclease/exonuclease/phosphatase family domain-containing protein 1 (sprot)

description: An endonuclease/exonuclease/phosphatase family domain-containing protein 1 that is encoded in the genome of mouse.


name: endonuclease/exonuclease/phosphatase family domain-containing protein 1

description: A protein that is a translation product of the human EEPD1 gene or a 1:1 ortholog thereof.


name: endonuclease/exonuclease/phosphatase family domain-containing protein 1 isoform 1 (human)

description: An endonuclease/exonuclease/phosphatase family domain-containing protein 1 isoform 1 that is encoded in the genome of human.


name: EEPD1_DANRE Endonuclease/exonuclease/phosphatase family domain-containing protein 1 (sprot)

description: An endonuclease/exonuclease/phosphatase family domain-containing protein 1 that is encoded in the genome of zebrafish.


name: EEPD1_RAT Endonuclease/exonuclease/phosphatase family domain-containing protein 1 (sprot)

description: An endonuclease/exonuclease/phosphatase family domain-containing protein 1 that is encoded in the genome of rat.


name: endonuclease/exonuclease/phosphatase family domain-containing protein 1 isoform 1

description: An endonuclease/exonuclease/phosphatase family domain-containing protein 1 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q7L9B9-1 or a 1:1 ortholog thereof.


name: endonuclease/exonuclease/phosphatase family domain-containing protein 1, initiator methionine removed form (human)

description: An endonuclease/exonuclease/phosphatase family domain-containing protein 1 (human) that has had the initiator methionine removed. UniProtKB:Q7L9B9, 2-569.


name: endonuclease/exonuclease/phosphatase family domain-containing protein 1 isoform 1 (rat)

description: An endonuclease/exonuclease/phosphatase family domain-containing protein 1 isoform 1 that is encoded in the genome of rat.


name: endonuclease/exonuclease/phosphatase family domain-containing protein 1 isoform 1 (mouse)

description: An endonuclease/exonuclease/phosphatase family domain-containing protein 1 isoform 1 that is encoded in the genome of mouse.


name: RF1M_MOUSE Peptide chain release factor 1, mitochondrial (sprot)

description: A peptide chain release factor 1, mitochondrial that is encoded in the genome of mouse.


name: phospholipid-transporting ATPase ABCA7 isoform h1 (human)

description: A phospholipid-transporting ATPase ABCA7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IZY2-1.


name: protein adenylyltransferase SelO, mitochondrial

description: A protein that is a translation product of the human SELO gene or a 1:1 ortholog thereof.


name: protein adenylyltransferase SelO, mitochondrial methylated 1 (human)

description: A protein adenylyltransferase SelO, mitochondrial (human) that has been methylated on the residue at the position equivalent to Cys-164 of the amino acid sequence represented by UniProtKB:Q9BVL4. UniProtKB:Q9BVL4, Cys-164, MOD:00660.


name: SELO_MOUSE Protein adenylyltransferase SelO, mitochondrial (sprot)

description: A protein adenylyltransferase SelO, mitochondrial that is encoded in the genome of mouse.


name: SELO_HUMAN Protein adenylyltransferase SelO, mitochondrial (sprot)

description: A protein adenylyltransferase SelO, mitochondrial that is encoded in the genome of human.


name: SELO1_DANRE Protein adenylyltransferase SelO-1, mitochondrial (sprot)

description: A protein adenylyltransferase SelO, mitochondrial that is encoded in the genome of zebrafish.


name: putative tyrosine-protein kinase F09A5.2 isoform b (worm)

description: A putative tyrosine-protein kinase F09A5.2 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q19238-1.


methyl alpha-D-galactoside

An alpha-D-galactoside having a methyl substituent at the anomeric position.


name: (6-4)DNA photolyase isoform 2 (Arabidopsis thaliana)

description: A (6-4)DNA photolyase (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O48652-2.


UVR3_ARATH (6-4)DNA photolyase (sprot)

A protein that is a translation product of the UVR3 gene in Arabidopsis thaliana.


name: (6-4)DNA photolyase isoform 1 (Arabidopsis thaliana)

description: A (6-4)DNA photolyase (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O48652-1.


name: heat shock factor protein 4 isoform hHSF4B (human)

description: A heat shock factor protein 4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9ULV5-1.


name: negative regulation of penicillin catabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways leading to the breakdown of any antibiotic that contains the condensed beta-lactamthiazolidine ring system.


name: regulation of cellular ketone metabolic process

description: Any process that modulates the chemical reactions and pathways involving any of a class of organic compounds that contain the carbonyl group, CO, and in which the carbonyl group is bonded only to carbon atoms. The general formula for a ketone is RCOR, where R and R are alkyl or aryl groups.


name: negative regulation of lysine biosynthetic process via alpha-aminoadipate and saccharopine

description: Any process that stops, prevents or reduces the frequency, rate or extent of lysine biosynthetic process via alpha-aminoadipate and saccharopine.


name: positive regulation of fatty acid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fatty acids.


name: negative regulation of fumonisin biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of fumonisin biosynthetic process.


name: regulation of initiation of acetate catabolic process by acetate

description: Any process that modulates the activation, by acetate, of the chemical reactions and pathways resulting in the breakdown of acetate.


name: negative regulation of tetrapyrrole biosynthetic process from glutamate

description: Any process that stops, prevents or reduces the frequency, rate or extent of tetrapyrrole biosynthetic process from glutamate.


name: negative regulation of tensidol A biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of tensidol A biosynthetic process.


name: regulation of polyketide biosynthetic process

description: Any process that modulates the frequency, rate or extent of polyketide biosynthetic process.


name: regulation of citrulline biosynthetic process

description: Any process that modulates the frequency, rate or extent of citrulline biosynthetic process.


name: regulation of arginine catabolic process

description: Any process that modulates the frequency, rate or extent of arginine catabolic process.


name: positive regulation of androst-4-ene-3,17-dione biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of androst-4-ene-3,17-dione biosynthetic process.


name: positive regulation of L-glutamine biosynthetic process

description: Any process that starts, increases the frequency, rate or extent of L-glutamine biosynthesis.


name: regulation of proline biosynthetic process

description: Any process that modulates the frequency, rate or extent of proline biosynthetic process.


name: negative regulation of retinoic acid biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of retinoic acid biosynthetic process.


name: regulation of ketone biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a ketone, carried out by individual cells.


name: negative regulation of androst-4-ene-3,17-dione biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of androst-4-ene-3,17-dione biosynthetic process.


name: positive regulation of ecdysteroid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of ecdysteroids.


name: positive regulation of L-leucine biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of L-leucine biosynthetic process.


name: regulation of L-dopa biosynthetic process

description: Any process that modulates the frequency, rate or extent of L-dopa biosynthetic process.


name: regulation of 'de novo' NAD biosynthetic process from tryptophan

description: Any process that modulates the frequency, rate or extent of 'de novo' NAD biosynthetic process from tryptophan.


name: negative regulation of citrulline biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of citrulline biosynthetic process.


name: negative regulation of xanthone-containing compound biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of xanthone-containing compound biosynthetic process.


name: negative regulation of gibberellin biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of gibberellins.


name: negative regulation of palmitic acid catabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of a palmitic acid catabolic process.


name: negative regulation of lysine biosynthetic process via aminoadipic acid

description: Any process that stops, prevents or reduces the frequency, rate or extent of lysine biosynthetic process via aminoadipic acid.


name: positive regulation of palmitic acid catabolic process

description: Any process that activates or increases the frequency, rate or extent of a palmitic acid catabolic process.


name: regulation of L-glutamine biosynthetic process

description: Any process that modulates the rate, frequency or extent of L-glutamine biosynthesis.


name: regulation of asperthecin biosynthetic process

description: Any process that modulates the frequency, rate or extent of asperthecin biosynthetic process.


name: negative regulation of butyryl-CoA biosynthetic process from acetyl-CoA

description: Any process that stops, prevents or reduces the frequency, rate or extent of butyryl-CoA biosynthetic process from acetyl-CoA.


name: regulation of butyryl-CoA biosynthetic process from acetyl-CoA

description: Any process that modulates the frequency, rate or extent of butyryl-CoA biosynthetic process from acetyl-CoA.


name: regulation of F-9775A biosynthetic process

description: Any process that modulates the frequency, rate or extent of F-9775A biosynthetic process.


name: regulation of ferulate catabolic process

description: Any process that modulates the frequency, rate or extent of ferulate catabolic process.


name: negative regulation of fatty acid biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fatty acids.


name: regulation of lysine biosynthetic process via alpha-aminoadipate and saccharopine

description: Any process that modulates the frequency, rate or extent of lysine biosynthetic process via alpha-aminoadipate and saccharopine.


name: negative regulation of L-leucine biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of L-leucine biosynthetic process.


name: regulation of naphtho-gamma-pyrone biosynthetic process

description: Any process that modulates the frequency, rate or extent of naphtho-gamma-pyrone biosynthetic process.


name: regulation of helvolic acid biosynthetic process

description: Any process that modulates the frequency, rate or extent of helvolic acid biosynthetic process.


name: positive regulation of unsaturated fatty acid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of unsaturated fatty acid biosynthetic process.


name: regulation of butyryl-CoA catabolic process to butyrate

description: Any process that modulates the frequency, rate or extent of butyryl-CoA catabolic process to butyrate.


name: regulation of testosterone biosynthetic process

description: Any process that modulates the frequency, rate or extent of testosterone biosynthetic process.


name: regulation of glutamate metabolic process

description: Any process that modulates the frequency, rate or extent of glutamate metabolic process.


name: regulation of prostaglandin biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of prostaglandin.


name: positive regulation of amino acid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of cellular amino acid biosynthetic process.


name: regulation of gamma-aminobutyric acid catabolic process

description: Any process that modulates the frequency, rate or extent of gamma-aminobutyric acid catabolic process.


name: regulation of gerfelin biosynthetic process

description: Any process that modulates the frequency, rate or extent of gerfelin biosynthetic process.


name: regulation of arginine biosynthetic process via ornithine

description: Any process that modulates the frequency, rate or extent of arginine biosynthetic process via ornithine.


name: negative regulation of L-ascorbic acid biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of L-ascorbic acid biosynthetic process.


name: regulation of palmitic acid catabolic process

description: Any process that modulates the frequency, rate or extent of a palmitic acid catabolic process.


name: negative regulation of L-glutamine biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of L-glutamine biosynthesis.


name: regulation of asperfuranone biosynthetic process

description: Any process that modulates the frequency, rate or extent of asperfuranone biosynthetic process.


name: regulation of progesterone biosynthetic process

description: Any process that modulates the frequency, rate or extent of progesterone biosynthetic process.


name: regulation of fatty acid metabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving fatty acids.


name: negative regulation of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of isopentenyl diphosphate produced via the methylerythritol (MEP) pathway (mevalonate-independent).


name: negative regulation of abscisic acid biosynthetic process

description: Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of abscisic acid.


name: regulation of histidine biosynthetic process

description: Any process that modulates the frequency, rate or extent of histidine biosynthetic process.


name: regulation of ecdysteroid metabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving ecdysteroids, a group of polyhydroxylated ketosteroids which initiate post-embryonic development, including the metamorphosis of immature forms and the development of the reproductive system and the maturation of oocytes in adult females.


name: regulation of bile acid biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of bile acids.


name: negative regulation of ubiquinone biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of ubiquinone biosynthetic process.


name: negative regulation of monodictyphenone biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of monodictyphenone biosynthetic process.


name: positive regulation of bile acid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of bile acids.


name: regulation of tryptophan metabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving tryptophan, the chiral amino acid 2-amino-3-(1H-indol-3-yl)propanoic acid.


name: regulation of acyl-CoA biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of acyl-CoA.


regulation of ketone catabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a ketone, carried out by individual cells.


name: positive regulation of initiation of acetate catabolic process by acetate

description: Any process that activates or increases the frequency, rate or extent of the activation, by acetate, of the chemical reactions and pathways resulting in the breakdown of acetate.


name: positive regulation of kojic acid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of kojic acid biosynthetic process.


name: regulation of jasmonic acid biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of jasmonic acid.


name: regulation of tensidol A biosynthetic process

description: Any process that modulates the frequency, rate or extent of tensidol A biosynthetic process.


name: negative regulation of homocysteine metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving homocysteine.


name: regulation of proline catabolic process to glutamate

description: Any process that modulates the frequency, rate or extent of proline catabolic process to glutamate.


name: positive regulation of penicillin catabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways leading to the breakdown of any antibiotic that contains the condensed beta-lactamthiazolidine ring system.


name: positive regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase

description: Any process that activates or increases the frequency, rate or extent of fatty acid beta-oxidation using acyl-CoA dehydrogenase.


name: negative regulation of ferulate catabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of ferulate catabolic process.


name: negative regulation of tetrapyrrole biosynthetic process from glycine and succinyl-CoA

description: Any process that stops, prevents or reduces the frequency, rate or extent of tetrapyrrole biosynthetic process from glycine and succinyl-CoA.


name: negative regulation of acetate catabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of acetate.


name: positive regulation of methane biosynthetic process from formic acid

description: Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from formic acid.


name: negative regulation of proline catabolic process to glutamate

description: Any process that stops, prevents or reduces the frequency, rate or extent of proline catabolic process to glutamate.


name: positive regulation of penicillin metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving any antibiotic that contains the condensed beta-lactamthiazolidine ring system.


name: positive regulation of ferulate catabolic process

description: Any process that activates or increases the frequency, rate or extent of ferulate catabolic process.


name: negative regulation of gamma-aminobutyric acid catabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of gamma-aminobutyric acid catabolic process.


name: regulation of cysteine metabolic process

description: Any process that modulates the frequency, rate or extent of cysteine metabolic process.


name: regulation of glutamine family amino acid metabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving amino acids of the glutamine family, comprising arginine, glutamate, glutamine and proline.


name: positive regulation of cysteine metabolic process

description: Any process that activates or increases the frequency, rate or extent of cysteine metabolic process.


name: positive regulation of butyryl-CoA biosynthetic process from acetyl-CoA

description: Any process that activates or increases the frequency, rate or extent of butyryl-CoA biosynthetic process from acetyl-CoA.


name: negative regulation of naphtho-gamma-pyrone biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of naphtho-gamma-pyrone biosynthetic process.


name: negative regulation of cellular glucuronidation

description: Any process that stops, prevents or reduces the frequency, rate or extent of cellular glucuronidation.


name: regulation of endocrocin biosynthetic process

description: Any process that modulates the frequency, rate or extent of endocrocin biosynthetic process.


name: regulation of ubiquinone biosynthetic process

description: Any process that modulates the frequency, rate or extent of ubiquinone biosynthesis. Ubiquinone biosynthesis consists of the chemical reactions and pathways resulting in the formation of ubiquinone, a lipid-soluble electron-transporting coenzyme.


name: negative regulation of testosterone biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of testosterone biosynthetic process.


name: negative regulation of selenocysteine metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of selenocysteine metabolic process.


name: negative regulation of tensidol B biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of tensidol B biosynthetic process.


name: regulation of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of isopentenyl diphosphate produced via the methylerythritol (MEP) pathway (mevalonate-independent).


name: negative regulation of prostaglandin biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of prostaglandin.


name: regulation of F-9775B biosynthetic process

description: Any process that modulates the frequency, rate or extent of F-9775B biosynthetic process.


name: negative regulation of histidine biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of histidine biosynthetic process.


name: negative regulation of initiation of acetate catabolic process by acetate

description: Any process that stops or prevents the activation, by acetate, of the chemical reactions and pathways resulting in the breakdown of acetate.


name: positive regulation of fatty acid beta-oxidation

description: Any process that activates or increases the frequency, rate or extent of fatty acid beta-oxidation.


name: negative regulation of indoleacetic acid biosynthetic process via tryptophan

description: Any process that stops, prevents or reduces the frequency, rate or extent of indoleacetic acid biosynthetic process via tryptophan.


name: positive regulation of tryptophan metabolic process

description: Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving tryptophan, the chiral amino acid 2-amino-3-(1H-indol-3-yl)propanoic acid.


name: regulation of lysine biosynthetic process via aminoadipic acid

description: Any process that modulates the frequency, rate or extent of lysine biosynthetic process via aminoadipic acid.


name: negative regulation of penicillin biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of penicillin biosynthetic process.


name: negative regulation of ammonia assimilation cycle

description: Any process that stops, prevents or reduces the frequency, rate or extent of ammonia assimilation cycle.


name: negative regulation of glutamate metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of glutamate metabolic process.


name: positive regulation of abscisic acid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of abscisic acid.


name: positive regulation of ubiquinone biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of ubiquinone biosynthetic process.


name: negative regulation of methane biosynthetic process from 3-(methylthio)propionic acid

description: Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from 3-(methylthio)propionic acid.


regulation of glyoxylate cycle

description: Any process that modulates the frequency, rate or extent of glyoxylate cycle.


name: positive regulation of progesterone biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of progesterone biosynthetic process.


name: regulation of penicillin biosynthetic process

description: Any process that modulates the frequency, rate or extent of penicillin biosynthetic process.


name: regulation of methane biosynthetic process from 3-(methylthio)propionic acid

description: Any process that modulates the frequency, rate or extent of methane biosynthetic process from 3-(methylthio)propionic acid.


regulation of acetate catabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of acetate, the anion of acetic acid.


name: negative regulation of amino acid biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of an amino acid biosynthetic process.


name: positive regulation of homocysteine metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving homocysteine.


name: negative regulation of homoserine biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of homoserine biosynthetic process.


name: positive regulation of fever generation by positive regulation of prostaglandin biosynthesis

description: Any process that increases the rate or extent of fever generation via positive regulation of the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of prostaglandin.


name: regulation of homoserine biosynthetic process

description: Any process that modulates the frequency, rate or extent of homoserine biosynthetic process.


name: regulation of aldosterone metabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving aldosterone.


name: positive regulation of ecdysteroid metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving ecdysteroids.


name: positive regulation of acetate catabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of acetate.


name: negative regulation of gerfelin biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of gerfelin biosynthetic process.


name: positive regulation of tetrapyrrole biosynthetic process from glycine and succinyl-CoA

description: Any process that activates or increases the frequency, rate or extent of tetrapyrrole biosynthetic process from glycine and succinyl-CoA.


name: negative regulation of ecdysteroid metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving ecdysteroids.


name: regulation of fumonisin biosynthetic process

description: Any process that modulates the frequency, rate or extent of fumonisin biosynthetic process.


name: positive regulation of proline catabolic process to glutamate

description: Any process that activates or increases the frequency, rate or extent of proline catabolic process to glutamate.


name: regulation of penicillin catabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways leading to the breakdown of any antibiotic that contains the condensed beta-lactamthiazolidine ring system.


name: regulation of gibberellin biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of gibberellins.


name: negative regulation of emericellin biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of emericellin biosynthetic process.


positive regulation of glyoxylate cycle

description: Any process that activates or increases the frequency, rate or extent of glyoxylate cycle.


name: regulation of retinoic acid biosynthetic process

description: Any process that modulates the frequency, rate or extent of retinoic acid biosynthetic process.


name: negative regulation of endocrocin biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of endocrocin biosynthetic process.


name: regulation of emericellin biosynthetic process

description: Any process that modulates the frequency, rate or extent of emericellin biosynthetic process.


name: negative regulation of cysteine metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of cysteine metabolic process.


name: positive regulation of cellular glucuronidation

description: Any process that activates or increases the frequency, rate or extent of cellular glucuronidation.


name: regulation of arginine biosynthetic process

description: Any process that modulates the frequency, rate or extent of arginine biosynthetic process.


name: positive regulation of retinoic acid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of retinoic acid biosynthetic process.


regulation of proline metabolic process

description: Any process that modulates the frequency, rate or extent of proline metabolic process.


name: negative regulation of asperthecin biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of asperthecin biosynthetic process.


name: regulation of aldosterone biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of aldosterone.


name: positive regulation of prostaglandin biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of prostaglandin.


name: negative regulation of kojic acid biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of kojic acid biosynthetic process.


name: regulation of tensidol B biosynthetic process

description: Any process that modulates the frequency, rate or extent of tensidol B biosynthetic process.


name: negative regulation of neosartoricin biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of neosartoricin biosynthetic process.


name: negative regulation of aldosterone biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of aldosterone.


name: positive regulation of proline metabolic process

description: Any process that activates or increases the frequency, rate or extent of proline metabolic process.


name: regulation of fever generation by regulation of prostaglandin biosynthesis

description: Any process that modulates the rate or extent of fever generation via regulation of the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of prostaglandin.


name: negative regulation of arginine catabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of arginine catabolic process.


name: regulation of selenocysteine metabolic process

description: Any process that modulates the frequency, rate or extent of selenocysteine metabolic process.


name: positive regulation of gibberellin biosynthetic process

description: Any process that activates, maintains or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of gibberellins.


name: positive regulation of glutamate metabolic process

description: Any process that activates or increases the frequency, rate or extent of glutamate metabolic process.


name: positive regulation of L-dopa biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of L-dopa biosynthetic process.


name: positive regulation of ammonia assimilation cycle

description: Any process that activates or increases the frequency, rate or extent of ammonia assimilation cycle.


name: positive regulation of fatty acid oxidation

description: Any process that activates or increases the frequency, rate or extent of fatty acid oxidation.


name: positive regulation of homoserine biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of homoserine biosynthetic process.


name: positive regulation of arginine biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of arginine biosynthetic process.


name: regulation of methane biosynthetic process from formic acid

description: Any process that modulates the frequency, rate or extent of methane biosynthetic process from formic acid.


initiation of acetate catabolic process

description: The activation of the chemical reactions and pathways resulting in the breakdown of acetate.


regulation of cellular glucuronidation

description: Any process that modulates the frequency, rate or extent of cellular glucuronidation.


name: negative regulation of helvolic acid biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of helvolic acid biosynthetic process.


name: negative regulation of butyryl-CoA catabolic process to butyrate

description: Any process that stops, prevents or reduces the frequency, rate or extent of butyryl-CoA catabolic process to butyrate.


name: regulation of abscisic acid biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of abscisic acid.


name: regulation of 1-aminocyclopropane-1-carboxylate metabolic process

description: Regulation of the chemical reactions and pathways involving 1-aminocyclopropane-1-carboxylate, the anion of 1-aminocyclopropane-1-carboxylic acid, a natural product found in plant tissues. It is a key intermediate in the biosynthesis of ethylene (ethene), a fruit-ripening hormone in plants.


name: positive regulation of fatty acid metabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving fatty acids.


name: positive regulation of selenocysteine metabolic process

description: Any process that activates or increases the frequency, rate or extent of selenocysteine metabolic process.


name: negative regulation of polyketide biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of polyketide biosynthetic process.


name: negative regulation of L-dopa biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of L-dopa biosynthetic process.


name: regulation of androst-4-ene-3,17-dione biosynthetic process

description: Any process that modulates the frequency, rate or extent of androst-4-ene-3,17-dione biosynthetic process.


name: positive regulation of lysine biosynthetic process via alpha-aminoadipate and saccharopine

description: Any process that activates or increases the frequency, rate or extent of lysine biosynthetic process via alpha-aminoadipate and saccharopine.


name: regulation of ammonia assimilation cycle

description: Any process that modulates the frequency, rate or extent of ammonia assimilation cycle.


name: regulation of tetrapyrrole biosynthetic process from glutamate

description: Any process that modulates the frequency, rate or extent of tetrapyrrole biosynthetic process from glutamate.


name: regulation of ecdysteroid biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of ecdysteroids.


name: positive regulation of gamma-aminobutyric acid catabolic process

description: Any process that activates or increases the frequency, rate or extent of gamma-aminobutyric acid catabolic process.


name: negative regulation of progesterone biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of progesterone biosynthetic process.